Clinic for Anesthesia, Resuscitation and Pain Management, Clinical Center of Montenegro, Podgorica, Montenegro.
Faculty of Medicine, University of Montenegro, Podgorica, Montenegro.
Med Sci Monit. 2023 Jan 27;29:e939204. doi: 10.12659/MSM.939204.
BACKGROUND Abdominal surgery is associated with a systemic inflammatory response which facilitates postoperative complications through immune imbalance and hypercatabolism. The aim of the study was to evaluate the effect of the combined perioperative lidocaine, magnesium, and amino acids on postoperative inflammation and pain. MATERIAL AND METHODS This prospective, randomized, double-blind study included 2 groups of patients undergoing abdominal surgery: Group 1 - receiving the aforementioned substances; and Group 2 - control (undergoing conventional general anesthesia). The following parameters were evaluated intraoperatively: arterial blood pressure, end-tidal CO₂ level, urine output, bispectral index, base excess, oxygen saturation, operating room temperature and body temperature (BT), opioid use, and surgery duration; and postoperatively: total leukocyte (WBC), neutrophil, lymphocyte and platelet count; fibrinogen, C-reactive protein (CRP), procalcitonin (PCT) and interleukin (IL)-6 levels; numeric rating scale (NRS) pain level, first flatus and bowel movement, and postoperative complications. The postoperative parameters were evaluated 2 h and 6 h postoperatively, as well as on postoperative days (POD) 1, 2, 3, and 5. RESULTS Group 1 showed lower counts of WBC, neutrophils, and lymphocytes and lower fibrinogen, CRP, PCT, IL-6, and BT in the first 5 POD, as well as NRS scores and time to first flatus/bowel movement. The groups did not differ significantly regarding postoperative complications. CONCLUSIONS The isolated effects of lidocaine, magnesium, and amino acids in surgery have been described previously. To the best of our knowledge, this is the first study to show the anti-inflammatory and analgesic effects of simultaneous use of these substances in abdominal surgery.
腹部手术会引起全身炎症反应,通过免疫失衡和过度分解代谢促进术后并发症的发生。本研究旨在评估围手术期利多卡因、镁和氨基酸联合应用对术后炎症和疼痛的影响。
本前瞻性、随机、双盲研究纳入了两组行腹部手术的患者:组 1 接受上述物质;组 2 为对照组(接受常规全身麻醉)。术中评估以下参数:动脉血压、呼气末二氧化碳水平、尿量、脑电双频指数、碱剩余、氧饱和度、手术室温度和体温(BT)、阿片类药物使用和手术时间;术后评估:白细胞(WBC)、中性粒细胞、淋巴细胞和血小板计数;纤维蛋白原、C 反应蛋白(CRP)、降钙素原(PCT)和白细胞介素(IL)-6 水平;数字评分量表(NRS)疼痛水平、首次排气和排便以及术后并发症。术后参数在术后 2 小时和 6 小时以及术后第 1、2、3 和 5 天进行评估。
组 1 在术后第 1 至 5 天,WBC、中性粒细胞和淋巴细胞计数较低,纤维蛋白原、CRP、PCT、IL-6 和 BT 较低,NRS 评分和首次排气/排便时间也较短。两组术后并发症无显著差异。
利多卡因、镁和氨基酸在手术中的单独作用先前已有描述。据我们所知,这是首次研究表明这些物质同时应用于腹部手术具有抗炎和镇痛作用。